{
    "title": "115_s523",
    "content": "The \"Budgeting for Opioid Addiction Treatment Act\" establishes a stewardship fee on opioid pain relievers under the Internal Revenue Code of 1986. The \"Budgeting for Opioid Addiction Treatment Act\" imposes a fee of 1 cent per milligram on the sale of active opioids by manufacturers, producers, or importers. Active opioids are defined as controlled substances derived from opium or opiates, excluding prescription drugs used solely for opioid addiction treatment. The \"Budgeting for Opioid Addiction Treatment Act\" imposes a fee on active opioids, excluding prescription drugs for addiction treatment. Subsection (a) applies to the active opioid portion only. Clerical amendments rename subchapter E to \"Other Medical Products\" in the Internal Revenue Code of 1986. The table of sections for subchapter E of chapter 32 of the Internal Revenue Code of 1986 is amended by adding a new item. The amendments made by this section regarding opioid pain relievers will apply to sales one year after the enactment of the Act. The Secretary of Health and Human Services will establish a rebate or discount program for eligible cancer and hospice patients related to the stewardship fee under section 4192 of the Internal Revenue Code. The Secretary will establish a program to discount opioids for eligible cancer and hospice patients to ensure no economic burden from the stewardship fee. Eligible patients include those prescribed opioids for cancer-related pain, hospice care participants, and in cases of death or incapacity. In cases of death or incapacity, the appropriate family member, medical proxy, or estate of the patient can make decisions for the patient. SEC. 3. BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE. Amends grants to states for prevention and treatment of substance abuse. Nonapplicability of Prevention Program Provision is amended. Opioid Treatment Programs are expanded with the addition of SEC. 1923A for additional substance abuse treatment programs. The funding agreement for a grant under section 1921 requires the State to use any increased revenues from the Treasury for substance abuse treatment efforts, including establishing new treatment facilities, sober living facilities, and increasing reimbursement for mental health providers. The curr_chunk discusses expanding access to substance abuse treatment programs in underserved communities, providing long-term residential treatment for opioid addicts, offering support services for recovering addicts, housing for children of parents in treatment, and care for babies born with neonatal abstinence. The curr_chunk discusses additional funding for substance abuse treatment programs, including care for babies born with neonatal abstinence syndrome and recruitment of professionals for rural communities. The curr_chunk discusses the requirement for a report. The Secretary of Health and Human Services must report to Congress within 2 years on the impact of recent amendments on opioid retail costs, patient access, revenue usage for substance abuse treatment, and suggestions for improvement. The Secretary of Health and Human Services must report to Congress within 2 years on the impact of recent amendments on opioid retail costs, patient access, revenue usage for substance abuse treatment, and suggestions for improving access to opioids for cancer and hospice patients, as well as substance abuse treatment efforts under section 1923A."
}